Media

Press releases and topics in the spotlight

Welcome to our media section. Check out the latest interviews, news, and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.

Media gallery

Latest pressreleases

See all Subscribe

In the spotlight

Watch the full presentation from Jefferies Global Healthcare Conference

2026-06-16

CEO Christer Ahlberg presents the company and the drug candidate, linaprazan glurate.

Cinclus Pharma is proud to be the Gold Sponsor of the OESO-SEMPIRE World Conference in Esophagology

2026-05-25

This international congress brings together leading experts, researchers and healthcare professionals from around the world to share knowledge, discuss the latest advances in esophagology, and shape the future of esophageal care and treatment.

Cinclus Pharma participates in Digestive Disease Week (DDW) in Chicago May 2-5 2026

2026-04-30

DDW brings together experts from across the globe for a comprehensive program of scientific sessions and networking opportunities.

CEO Christer Alhberg presents at Redeye Healthcare Day 2026

2026-04-15

Watch the full presentation by CEO Christer Ahlberg about Cinclus Pharma and the development of linaprazan glurate, presented at Redeye Healthcare Day 2026.

See all

Cinclus Pharma in media

Interview with Christer Ahlberg in BioStock

2026-06-09

Read article about Cinclus Pharma with interview with CEO Christer Ahlberg from BioStock (in Swedish).

Kjell Andersson in the Lonza Podcast: A View On: Developing Acid Reflux Therapy

2025-03-06

Kjell Anderson, Chief Scientific Officer and Founder of Cinclus Pharma, discusses a novel treatment for acid reflux in this episode ‘A View On: Developing Acid Reflux Therapy’ of the Lonza podcast.

Placera.se lists Swedish stocks offering the biggest upside

2025-01-02

Cinclus Pharma is on the list of analysts' favorite stocks when Placera.se lists Swedish stocks offering the biggest upside.

Bengt Julander on Cinclus Pharma in DITV

2024-12-11

Bengt Julander, Chairman of one of Cinclus Pharma's largest shareholders, Linc, participated in DITV, saying Cinclus Pharma has the world's best stomach ulcer treatment.